AMPH
NASDAQ
$19.59
Amphastar Pharmaceuticals Inc (AMPH)
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
Sector:
Healthcare
Hold
Target: $22 (+12.30%)
Market Cap
$866M
EPS 5Y CAGR
+101.37%
FCF 5Y CAGR
+24.53%
P/E Ratio
11.27
Price Chart
Valuation
Market Cap$866M
P/E11.27
PEG2.77
P/S1.22
P/B1.10
Profitability
Total Revenue (TTM)$721M
Gross Profit (TTM)$341M
EBITDA$149M
Profit Margin3.8%
Operating Margin8%
EPS$1.72
Financial Health
Free Cash Flow Yield15.61%
Growth & Risk
EPS 5Y CAGR+101.37%
Revenue 5Y CAGR+14.37%
FCF 5Y CAGR+24.53%
Beta (5Y)0.70
Sharpe Ratio0.13